LAUREN COLLIN: Open Payments
NPI 1568836773 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 36 payments from 7 companies in 2025. Trend: 2023 $64 · 2024 $439 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $401 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Inspire Medical Systems, Inc. | 1 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Verona Pharma, Inc. | 2 | $47 |
| Insmed, Inc. | 2 | $39 |
| Amgen Inc. | 1 | $28 |
Products named: NUCALA, INSPIRE, TRELEGY ELLIPTA, FASENRA, TEZSPIRE, Ohtuvayre, Arikayce, OFEV.
Industry payments across CT — which companies pay providers there.
